Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BOM/524717 stock hub

BOM/524717 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/524717is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

19.1B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/524717

In the news

Latest news · BOM/524717

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E70.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC12.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/524717 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

INR

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	467
Employees Change	18%
Employees Change Percent	4.01
Enterprise value	INR 19.2B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	INR 19.1B
Price	INR 463
Price currency	INR
Rev Per Employee	4,122,614.56x
Sic	2836
Symbol	bom/524717
Website	https://titanbiotechltd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.42%
EV Earnings	70.51x
EV/EBIT	61.1x
EV/EBITDA	53.02x
EV/Sales	9.96x
P/B ratio	11.49x
P/E ratio	70.32x
P/S ratio	9.94x
PE Ratio10 Y	13.57x
PE Ratio3 Y	19.07x
PE Ratio5 Y	15.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.98%
EBITDA Margin	17.23%
Gross margin	51.2%
Gross Profit	INR 985.8M
Gross Profit Growth	17.4%
Gross Profit Growth Q	46.14%
Gross Profit Growth3 Y	10.64%
Gross Profit Growth5 Y	6.51%
Net Income	INR 272M
Net Income Growth	21%
Net Income Growth Q	94.27%
Net Income Growth3 Y	3.02%
Net Income Growth5 Y	-0.93%
Pretax Margin	18.42%
Profit Margin	14.13%
Profit Per Employee	INR 582,503
Roa5y	16.7
Roe5y	28.74
ROIC	12.89
Roic5y	24.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	52.47%
Cagr15y	38.08%
Cagr1y	418.39%
Cagr20y	29.52%
Cagr3y	115.02%
Cagr5y	49.47%
Div CAGR10	10.31%
Div CAGR3	3.57%
Div CAGR5	5.92%
EPS Growth	20.99
EPS Growth Q	94.35
EPS Growth3 Y	3.02
EPS Growth5 Y	-0.93
Revenue Growth	19.43x
Revenue Growth Q	47.63x
Revenue Growth3 Y	11.12x
Revenue Growth5 Y	8.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 36M
Debt	INR 88.5M
Debt EBITDA	INR 0.26
Debt Equity	INR 0.05
Equity	INR 1.7B
Interest Coverage	73.19
Net Cash	INR -52.5M
Net Cash By Market Cap	INR -0.27
Net Debt EBITDA	INR 0.16
Net Debt Equity	INR 0.03
Tangible Book Value	INR 1.7B
Tangible Book Value Per Share	INR 40.27
WACC	1.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.4
Dividend Years	6
Dividend Yield	0.09%
Ex Div Date	2025-09-19
Last Dividend	INR 0.4
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	6,683.91%
1Y total return	417.8%
200-day SMA	236.5
3Y total return	894.67%
50-day SMA	403.2
50-day SMA vs 200-day SMA	50over200
5Y total return	645.71%
All Time High	555.7
All Time High Change	-16.68%
All Time High Date	2026-04-07
All Time Low	0.34
All Time Low Change	136,182.01%
All Time Low Date	2003-02-05
ATR	27.55
Beta	-0.48
Beta1y	-1.3
Beta2y	-0.59
Ch YTD	119.7
High	474
High52	555.7
High52 Date	2026-04-07
High52ch	-16.68%
Low	455
Low52	74.73
Low52 Date	2025-06-19
Low52ch	519.5%
Ma50ch	14.82%
Price vs 200-day SMA	95.71%
RSI	52.83
RSI Monthly	78.76
RSI Weekly	75.52
Sharpe ratio	2.77x
Sortino ratio	5.48
Total Return	0.08%
Tr YTD	119.7
Tr15y	12,544.17%
Tr1m	-8.02%
Tr1w	-6.69%
Tr3m	128.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 288.5M
Operating Income Growth	22.1
Operating Income Growth Q	161
Operating Income Growth3 Y	1.3
Operating Income Growth5 Y	-6.43
Operating margin	14.98

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,133,045%
Shares Insiders	8.72%
Shares Out	41,318,500
Shares Qo Q	0.05%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	61,099.5x
Bv Per Share	40.29
Ch10y	6,198.6
Ch15y	10,074.7
Ch1m	-8.02
Ch1w	-6.69
Ch1y	416.7
Ch20y	13,844.3
Ch3m	128.2
Ch3y	884.4
Ch5y	630.9
Ch6m	138
Change	-0.58%
Change From Open	-1.48
Close	465.7
Days Gap	0.91
Depreciation Amortization	43,239,750
Dollar Volume	8,889,103
Earnings Date	2026-05-29
EBIT	INR 288.5M
EBITDA	INR 331.7M
EPS	INR 6.58
F Score	1
Fiscal Year End	March
Founded	1,992
Graham Number	77.25367
Graham Upside	-83.31
Income Tax	INR 82.6M
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Last Split Date	2026-02-20
Last Split Type	Forward
Lynch Fair Value	INR 32.92
Lynch Upside	-92.89
Ma150	275.5
Ma150ch	68.07%
Ma20	466.6
Ma20ch	-0.77%
Next Earnings Date	2026-05-29
Open	469.9
Payment Date	2025-10-26
Position In Range	41.95
Price Date	2026-05-08
Price EBITDA	INR 57.67
Ptbv Ratio	11.5
Relative Volume	0.31x
Revenue	1,925,261,000x
Tax By Revenue	4.29x
Tax Rate	23.3%
Tr20y	17,552.51%
Tr6m	138.03%
Volume	19,201

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BOM/524717 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.40 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.9%

0 consecutive years of growth

Total shareholder yield

+0.1%

Next ex-dividend date: 2025-09-19

Performance

BOM/524717 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/524717?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+8.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

BOM/524717 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.8

Neutral momentum band

Price vs 200-day MA

+95.7%

50/200-day relationship not available

Beta (5Y)

-0.48

Less volatile than the market

Sharpe ratio

2.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/524717

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/524717 stock rating?

bom/524717 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/524717 analysis?

The full report lives at /stocks/bom/524717/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/524717?

The latest report frames bom/524717 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/524717 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.